Biogen Idec searching for genetic causes of ALS

Biogen Idec, Duke University, and the HudsonAlpha Institute for Biotechnology have agreed to sequence the genomes of 1,000 ALS patients. The goal of the ambitious collaboration is to identify and better understand the causes of ALS at the genetic level. The team hopes that this additional information will help with identifying potential new ALS therapies.

Click here to read more.

Share this: